Pregnancy rate with 1 week versus 2 weeks of hormonal therapy

Phase 1

• Conditions: Subfertility in need of IVF and IVF-ICSI treatment; MedDRA version: 20.0 Level: LLT Classification code 10042391 Term: Subfertility System Organ Class: 100000004872; Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]

• Registration Number: EUCTR2018-000689-13-BE
• Lead Sponsor: niversity hospital Brussel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-06-07
• Last Update Posted: 30 June 2019

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

•Women aged =18 and < 40 years
•Unexplained infertility
•Normal uterine cavity
•IVF/ICSI
•IVF cycle with GnRH agonist or an-tagonist
•Single day 5 blastocyst transfer
•Top quality embryo (at least Bl 3BA) at the moment of ET
•Signed informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 150
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Body mass index of =18 and = 29
•Previous diagnosis of PCOS/POI
•Endometriosis stage 3 and 4
•Previous diagnosis of hydrosalpinx
•Systemic diseases such as thyroid dysfunction, unless corrected
•History of recurrent implantation failure or recurrent miscar-riage
•PGD/PGS cycles
•Oocytes donation cycles

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified